TrialClinical immunology (Orlando, Fla.)2025

A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis.

V Koneti Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.